rosiglitazone has been researched along with lentinan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, DG; Li, JL; Liu, Q; Sun, DQ; Sun, XB; Sun, XG | 1 |
1 other study(ies) available for rosiglitazone and lentinan
| Article | Year |
|---|---|
Lentinan depresses 3T3-L1 fat cell formation by inhibiting PPARĪ³/AKT signaling pathway.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Cell Differentiation; Gene Expression Regulation; Lentinan; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2015 |